Literature DB >> 11495559

Human papillomavirus typing in HIV-positive women.

M Hameed1, H Fernandes, J Skurnick, D Moore, P Kloser, D Heller.   

Abstract

OBJECTIVE: Human papillomavirus (HPV) is the major cause of cervical carcinoma and cervical intraepithelial neoplasia worldwide. Certain HPV types have a strong association with and probably a causative role in the pathogenesis of premalignant cervical lesions. Epidemiologic studies in women infected by the human immunodeficiency virus (HIV) have shown an increased incidence of squamous intraepithelial lesions (SILs), which were predominantly high-grade. Six to 30 per cent of women diagnosed with atypical squamous cells of undetermined significance (ASCUS) on a Papanicolaou (Pap) smear harbor SIL in normal screening populations. This study was undertaken to determine the presence of low-and high-risk HPV types in women infected by HIV and to correlate the results to those of the Pap smear. STUDY
DESIGN: HPV DNA typing (low- and high-risk) by Digene (Digene Corporation, Gathesburg, MD) hybrid capture methodology was performed on cervical swabs from 209 HIV-positive women. The results of HPV typing were correlated with those of the Pap smear in a retrospective analysis.
RESULTS: One hundred and one women (48%) tested positive for HPV subtypes by DNA typing by the hybrid capture method. Of these, 64 patients (63%) had Pap smears which were read as being normal, having benign cellular changes, or having ASCUS (favor reactive process). Of these, 19 patients tested positive for both high-risk and low-risk subtypes, 32 patients tested positive only for high-risk subtypes, and 13 patients tested positive only for low-risk subtypes.
CONCLUSION: HPV subtyping identifies a significant group of HIV-positive women who are at risk for developing cervical intraepithelial neoplasia, although they may not show significant abnormalities on their Pap smears.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11495559      PMCID: PMC1784640          DOI: 10.1155/S1064744901000163

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  28 in total

Review 1.  Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia.

Authors:  M H Schiffman
Journal:  J Natl Cancer Inst       Date:  1992-03-18       Impact factor: 13.506

2.  Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection?

Authors:  R Reid; M D Greenberg; A Lorincz; A B Jenson; C R Laverty; M Husain; Y Daoud; B Zado; T White; D Cantor
Journal:  Am J Obstet Gynecol       Date:  1991-06       Impact factor: 8.661

Review 3.  Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions.

Authors:  J S Mandelblatt; M Fahs; K Garibaldi; R T Senie; H B Peterson
Journal:  AIDS       Date:  1992-02       Impact factor: 4.177

4.  Persistence of type-specific human papillomavirus infection among cytologically normal women.

Authors:  A Hildesheim; M H Schiffman; P E Gravitt; A G Glass; C E Greer; T Zhang; D R Scott; B B Rush; P Lawler; M E Sherman
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

5.  Human papillomavirus detection by hybrid capture and its possible clinical use.

Authors:  A Farthing; P Masterson; W P Mason; K H Vousden
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

6.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.

Authors:  L A Koutsky; K K Holmes; C W Critchlow; C E Stevens; J Paavonen; A M Beckmann; T A DeRouen; D A Galloway; D Vernon; N B Kiviat
Journal:  N Engl J Med       Date:  1992-10-29       Impact factor: 91.245

7.  The correlation between HIV seropositivity, cervical dysplasia, and HPV subtypes 6/11, 16/18, 31/33/35.

Authors:  G Tweddel; P Heller; M Cunnane; H Multhaupt; K Roth
Journal:  Gynecol Oncol       Date:  1994-02       Impact factor: 5.482

8.  Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction.

Authors:  Y Fujinaga; M Shimada; K Okazawa; M Fukushima; I Kato; K Fujinaga
Journal:  J Gen Virol       Date:  1991-05       Impact factor: 3.891

9.  Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected].

Authors:  J Cuzick; G Terry; L Ho; T Hollingworth; M Anderson
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

10.  Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression.

Authors:  G Y Ho; R D Burk; I Fleming; R S Klein
Journal:  Int J Cancer       Date:  1994-03-15       Impact factor: 7.396

View more
  1 in total

1.  Evidence of recombination within human alpha-papillomavirus.

Authors:  Manuel Angulo; Antonio Carvajal-Rodríguez
Journal:  Virol J       Date:  2007-03-28       Impact factor: 4.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.